Neovascular complications such as rubeosis and neovascular glaucoma (NVG) are more frequent in eyes with ischemic CRVO than in eyes with nonischemic CRVO; this is because of greater upregulation of vascular endothelial growth factor (VEGF) in the former. Here, VEGFA is linked to neovascular glaucoma.